International Clinical Trial: A Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study of TRX-100 Tablets Evaluating the Safety, Pharmacokinetics, and Food Effect of Single Ascending Doses of TRX-100 in Healthy Volunteers

Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ACTRN12626000272392) titled 'A Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study of TRX-100 Tablets Evaluating the Safety, Pharmacokinetics, and Food Effect of Single Ascending Doses of TRX-100 in Healthy Volunteers' on March 4.

Study Type: Interventional

Study Design: Purpose: Treatment Allocation: Randomised controlled trial

Primary Sponsor: Traws Pharma, Inc

Condition: Influenza Influenza Infection - Other infectious diseases

Intervention: The study drug is TRX-100 oral tablets. There are 2 cohorts in the study: - Cohort A: 8 participants will receive one dose of either TRX-100 240 mg or matching placebo under...